Results 171 to 180 of about 3,719,549 (330)
The location of R&D in the Netherlands: trends, determinants and policy [PDF]
Many factors determine the location of business R&D projects, the most important being history, the supply of R&D labour, and the quality of the public knowledge infrastructure (including the science-industry knowledge transfer). The set of R&D locations
Maarten Cornet, Marieke Rensman
core
A multifunctional nanodiamond platform enables pH‐triggered Diazoxide (DZX) delivery and quantum sensing of subcellular radical dynamics in triple‐negative breast cancer cells. Diamond relaxometry revealed reduced lysosomal radicals during DZX‐induced mitochondrial radical elevation, providing insights into redox modulation and organelle‐ resolved ...
Kaiqui Wu +8 more
wiley +1 more source
Correction: Extent and Boundaries of Lymph Node Stations During Minimally Invasive Esophagectomy: A Survey Among Dutch Esophageal Surgeons. [PDF]
Ketel MHM +7 more
europepmc +1 more source
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands [PDF]
Maite Timmermans +4 more
openalex +1 more source
Hours and income dynamics during the Covid-19 pandemic: The case of the Netherlands
Christian Zimpelmann +4 more
openalex +2 more sources
Wage Structure and Labor Mobility in the Netherlands 1999-2003 [PDF]
In this paper we document the wage structure and labor mobility in the Netherlands in the period 1999-2003. We explain the importance of wage-setting institutions in the Netherlands and the main actors.
Ben Kriechel, Lex Borghans
core
A 3D disease model is developed using customized hyaluronic‐acid‐based hydrogels supplemented with extracellular matrix (ECM) proteins resembling brain ECM properties. Neurons, astrocytes, and tumor cells are used to mimic the native brain surrounding.
Esra Türker +16 more
wiley +1 more source
Author Correction: Blood and tissue correlates of steroid non-response in checkpoint inhibition-induced immune-related adverse events. [PDF]
van Eijs MJM +11 more
europepmc +1 more source

